Xxera/openscience/retractions

Record #55621

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin

Journal

Psychopharmacology

Publisher

Original paper date

May 7, 2019

Original DOI

10.1007/s00213-019-05249-5

Country

🇨🇦 Canada · 🇺🇸 United States

Institution

Medical University of South Carolina, Charleston, SC, USA · MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA · Private Practice, Charleston, SC, USA · University of British Columbia–Okanagan, Kelowna, BC, Canada · Stanford School of Medicine, Stanford University, Stanford, CA, USA · Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA

Open access

No

Article type

Broad categories

(HSC) Medicine - Pharmacology (HSC) Medicine - Psychiatry

Notes from Retraction Watch

see also: https://www.statnews.com/2024/08/11/mdma-ptsd-lykos-maps-retractions/

Citation lifecycle

How this paper is being cited

Pre-retraction

269

Same day

0

Post-retraction

45

% post-retraction

14.3%

~51.1 citations/yr before retraction · ~21.4 citations/yr after

— citing papers

Who is still citing this work

Loading…